Dr. Benjamin Batson , DO
Internal Medicine - Pulmonary Disease โข Lubbock, TX
3621 22nd St Ste 400
Lubbock, TX 794101302
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Benjamin Batson is listed in NPPES under Internal Medicine - Pulmonary Disease.
-
NPI assigned on June 27, 2017; this date does not establish years in practice.
-
Published CMS data list 1,503 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99232 โ Subsequent hospital care with moderate levelof medical decision making: 253 service units.
- 99214 โ Established patient outpatient office visit: 193 service units.
- 99291 โ Critical care: 163 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 16 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 695 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) โ 238 prescription fills, including refills.
- Albuterol Sulfate Hfa (Albuterol Sulfate) โ 95 prescription fills, including refills.
- Breztri Aerosphere (Budesonide/Glycopyr/Formoterol) โ 39 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 20 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 60% of clinicians listed under Internal Medicine - Pulmonary Disease in Lubbock, TX (2024, 18 clinicians with data). Median for this group: 1,137. Middle half: 584 to 1,582.
More Medicare Part B services than 65% of clinicians listed under Internal Medicine - Pulmonary Disease in Texas (2024, 730 clinicians with data). Median for this group: 995. Middle half: 375 to 1,872.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 68 in 2020 to 1,503 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
3621 22nd St Ste 400
Lubbock, TX 794101302
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 1 additional practice-address record in Lubbock, TX. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 1 group name: Covenant Medical Group. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
University Of North Texas Hsc, College Of Osteopathic Med
2017
What Public CMS Data Show
Internal Medicine - Pulmonary Disease: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
355 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $119,084 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $92,718 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
891 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$277,239 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $2,963.21 across 112 records.
By nature of payment
- Food and Beverage: $2,552.81 across 109 records.
- Travel and Lodging: $394.16 across 2 records.
- Education: $16.24 across 1 record.
Reporting-company totals (3 largest of 16)
- AstraZeneca Pharmaceuticals LP: $671.90 across 14 records.
- GlaxoSmithKline, LLC.: $526.58 across 31 records.
- INTUITIVE SURGICAL, INC.: $468.46 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
9 years (graduated 2017)
CMS Doctors and Clinicians data list 2017 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2017
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Batson has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Batson as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Lubbock and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 60% of clinicians listed under Internal Medicine - Pulmonary Disease in Lubbock, TX (2024, 18 clinicians with data). Median for this group: 1,137. Middle half: 584 to 1,582.
More Medicare Part B services than 65% of clinicians listed under Internal Medicine - Pulmonary Disease in Texas (2024, 730 clinicians with data). Median for this group: 995. Middle half: 375 to 1,872.
Medicare-allowed amount
Close to the middle for clinicians listed under Internal Medicine - Pulmonary Disease in Lubbock, TX (2024, 18 clinicians with data). Median for this group: $105,875. Middle half: $58,028 to $123,495.
Close to the middle for clinicians listed under Internal Medicine - Pulmonary Disease in Texas (2024, 730 clinicians with data). Median for this group: $93,554. Middle half: $42,268 to $187,979.
Paid by Medicare
Close to the middle for clinicians listed under Internal Medicine - Pulmonary Disease in Lubbock, TX (2024, 18 clinicians with data). Median for this group: $82,975. Middle half: $45,817 to $96,131.
Close to the middle for clinicians listed under Internal Medicine - Pulmonary Disease in Texas (2024, 730 clinicians with data). Median for this group: $72,493. Middle half: $32,672 to $145,098.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Internal Medicine - Pulmonary Disease in Lubbock, TX (2024, 18 clinicians with data). Median for this group: 811. Middle half: 192 to 1,228.
Close to the middle for clinicians listed under Internal Medicine - Pulmonary Disease in Texas (2024, 676 clinicians with data). Median for this group: 762. Middle half: 212 to 1,928.
Part D drug cost
Close to the middle for clinicians listed under Internal Medicine - Pulmonary Disease in Lubbock, TX (2024, 18 clinicians with data). Median for this group: $474,435. Middle half: $169,108 to $784,527.
Close to the middle for clinicians listed under Internal Medicine - Pulmonary Disease in Texas (2024, 676 clinicians with data). Median for this group: $429,867. Middle half: $72,110 to $1,195,672.
22 active clinicians are listed under Internal Medicine - Pulmonary Disease with a practice address in Lubbock, TX (984 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Lubbock
9.1% of these 22 clinicians have the CMS telehealth indicator.
81.8% of these 22 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 2110% from 68 in 2020 to 1,503 in 2024.
- 2020: 68
- 2021: 60
- 2022: 24
- 2023: 329
- 2024: 1,503
-
Medicare-allowed amount
Medicare-allowed amount increased 2362% from $4,838 in 2020 to $119,084 in 2024.
- 2020: $4,838
- 2021: $4,172
- 2022: $2,975
- 2023: $26,433
- 2024: $119,084
-
Paid by Medicare
Paid by Medicare increased 2299% from $3,864 in 2020 to $92,718 in 2024.
- 2020: $3,864
- 2021: $3,337
- 2022: $2,348
- 2023: $21,070
- 2024: $92,718
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 69% from 412 in 2020 to 695 in 2024.
- 2020: 412
- 2021: 12
- 2022: 70
- 2023: 106
- 2024: 695
-
30-day fills
30-day fills increased 11% from 801 in 2020 to 891 in 2024.
- 2020: 801
- 2021: 12
- 2022: 82
- 2023: 140
- 2024: 891
-
Part D drug cost
Part D drug cost increased 2274% from $11,677 in 2020 to $277,239 in 2024.
- 2020: $11,677
- 2021: $38
- 2022: $21,765
- 2023: $36,879
- 2024: $277,239
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $528.10 in 2021 to $2,963.21 in 2025.
- 2021: $528.10
- 2022: $368.50
- 2023: $951.64
- 2024: $2,350.83
- 2025: $2,963.21
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 112 records totaling $2,963.21.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| INTUITIVE SURGICAL, INC. |
Travel and Lodging
In-kind items and services
|
Da Vinci Surgical System | General | $375.16 |
| Verona Pharma, Inc. |
Food and Beverage
Cash or cash equivalent
|
Ohtuvayre | General | $133.48 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FASENRA | General | $122.79 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $122.79 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $122.79 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FASENRA | General | $121.68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
OFEV | General | $99.96 |
| INTUITIVE SURGICAL, INC. |
Food and Beverage
In-kind items and services
|
Da Vinci Surgical System | General | $74.30 |
| Insmed, Inc. |
Food and Beverage
In-kind items and services
|
Arikayce | General | $69.09 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $35.09 |
| Grifols Shared Services North America, Inc. |
Food and Beverage
In-kind items and services
|
Prolastin-C Liquid | General | $32.91 |
| Insmed, Inc. |
Food and Beverage
In-kind items and services
|
Arikayce | General | $30.65 |
| Verona Pharma, Inc. |
Food and Beverage
Cash or cash equivalent
|
Ohtuvayre | General | $29.55 |
| Verona Pharma, Inc. |
Food and Beverage
Cash or cash equivalent
|
Ohtuvayre | General | $28.37 |
| Viatris Specialty LLC |
Food and Beverage
In-kind items and services
|
YUPELRI | General | $27.95 |
| Insmed, Inc. |
Food and Beverage
In-kind items and services
|
Arikayce | General | $26.81 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
AIRSUPRA | General | $26.57 |
| ABIOMED |
Food and Beverage
In-kind items and services
|
โ | General | $26.27 |
| Verona Pharma, Inc. |
Food and Beverage
Cash or cash equivalent
|
Ohtuvayre | General | $26.27 |
| Insmed, Inc. |
Food and Beverage
In-kind items and services
|
Arikayce | General | $25.69 |
| Grifols Shared Services North America, Inc. |
Food and Beverage
In-kind items and services
|
Prolastin-C Liquid | General | $25.53 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $25.39 |
| Verona Pharma, Inc. |
Food and Beverage
Cash or cash equivalent
|
Ohtuvayre | General | $25.33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
OFEV | General | $23.42 |
| Verona Pharma, Inc. |
Food and Beverage
Cash or cash equivalent
|
Ohtuvayre | General | $22.96 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2019โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2020โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
253 | 93 | $115.00 | $73.88 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
193 | 125 | $177.00 | $92.29 |
|
99291
Critical care, first 30-74 minutes
|
163 | 71 | $510.00 | $202.70 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
120 | 102 | $47.25 | $15.62 |
|
99233
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
|
118 | 76 | $167.00 | $112.75 |
|
94010
Test to measure expiratory airflow and volume
|
96 | 93 | $26.00 | $7.67 |
|
71045
X-ray of chest, 1 view
|
92 | 86 | $67.00 | $7.98 |
|
94727
Test to determine lung volumes using gas dilution or washout
|
78 | 77 | $39.00 | $11.19 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
78 | 78 | $285.00 | $126.23 |
|
94729
Test to examine how well the lungs exchange gases
|
76 | 75 | $28.00 | $8.30 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
62 | 55 | $125.00 | $62.27 |
|
71250
Ct scan of chest without contrast
|
47 | 40 | $336.00 | $77.74 |
|
99222
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
|
47 | 47 | $405.00 | $124.55 |
|
99223
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
|
38 | 38 | $600.00 | $160.96 |
|
94618
Test for exercise-induced lung stress
|
27 | 26 | $117.00 | $20.95 |
|
32555
Aspiration of fluid from chest cavity using imaging guidance
|
15 | 13 | $417.00 | $99.40 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 238 | 8,362 | $172,105.24 | 57 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 95 | 3,293 | $2,616.66 | 40 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 39 | 1,530 | $30,970.76 | 12 |
| Azithromycin | Azithromycin | 37 | 875 | $476.17 | 11 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 31 | 930 | $2,537.28 | 11 |
| Symbicort | Budesonide/Formoterol Fumarate | 30 | 1,200 | $9,204.41 | โ |
| Doxycycline Hyclate | Doxycycline Hyclate | 26 | 325 | $269.03 | 24 |
| Montelukast Sodium | Montelukast Sodium | 24 | 1,589 | $255.04 | โ |
| Ventolin Hfa | Albuterol Sulfate | 22 | 505 | $1,328.70 | โ |
| Prednisone | Prednisone | 20 | 308 | $58.88 | 19 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 16 | 870 | $11,516.75 | โ |
| Spiriva Handihaler | Tiotropium Bromide | 15 | 870 | $14,118.56 | โ |
| Breyna | Budesonide/Formoterol Fumarate | 15 | 426 | $2,892.30 | โ |
| Levofloxacin | Levofloxacin | 14 | 153 | $52.69 | 12 |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | 420 | $5,559.52 | โ |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 14 | 420 | $6,040.41 | โ |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 12 | 251 | $219.17 | 12 |
| Ipratropium Bromide | Ipratropium Bromide | 11 | 508 | $359.20 | โ |
| Spiriva Respimat | Tiotropium Bromide | 11 | 810 | $13,883.35 | โ |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 11 | 930 | $2,774.67 | โ |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2023-08-07NUCC Taxonomy Code: 207RP1001X
An internist who treats diseases of the lungs and airways. The pulmonologist diagnoses and treats cancer, pneumonia, pleurisy, asthma, occupational and environmental diseases, bronchitis, sleep disorders, emphysema and other complex disorders of the lungs.
NUCC Taxonomy Code: 207RC0200X
An internist who diagnoses, treats and supports patients with multiple organ dysfunction. This specialist may have administrative responsibilities for intensive care units and may also facilitate and coordinate patient care among the primary physician, the critical care staff and other specialists.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - PULMONARY DISEASE
I20191009001265
TX
4284969262
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Covenant Medical Group
3621 22nd St, Lubbock, TX 794101301
Phone: 8067918484
Secondary Practice Locations
3601 4th St # Ms 9410
Lubbock, TX 794300002
Phone: 8067433381
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner - Acute Care
Nurse Practitioner
Internal Medicine - Pulmonary Disease
Doctor of Medicine (M.D.)
Nurse Practitioner - Acute Care
Adult-Gerontology Acute Care Nurse Practitioner (Board Certified)
Internal Medicine - Pulmonary Disease
Doctor of Medicine (M.D.)
Internal Medicine - Pulmonary Disease
Doctor of Medicine (M.D.)
Internal Medicine - Pulmonary Disease
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 3621 22ND ST STE 400, LUBBOCK, TX 794101302 (Tel: 8067918484)
Registered at 2215 NASHVILLE AVE, LUBBOCK, TX 794101105 (Tel: 8067255844)
Additional practice office at 3601 4th St # MS 9410, Lubbock, TX 794300002
Internal Medicine (license number reported to NPPES: TX S1561)
NPI status registered as active in NPPES database
Registered at 3601 4TH ST # MS 9410, LUBBOCK, TX 794300002 (Tel: (806) 743-3381)
Registered at 3601 4TH ST # MS 9410, LUBBOCK, TX 794300002 (Tel: 8067433381)
Recorded as BENJAMIN BATSON, DO
Student in an Organized Health Care Education/Training Program (license number reported to NPPES: TX BP10059579)
Recorded as BENJAMIN BATSON, DO
NPI status registered as active in NPPES database
Registered at 3601 4TH ST # MS 9410, LUBBOCK, TX 794300002 (Tel: (806) 743-3381)
Registered at 3601 4TH ST # MS 9410, LUBBOCK, TX 794300002 (Tel: 8067433381)
Recorded as BENJAMIN BATSON, MD
Student in an Organized Health Care Education/Training Program (license number reported to NPPES: TX BP10059579)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine - Pulmonary Diseases in Lubbock
- Dr. Andrew Shakespeare, MD
- Dr. Cynthia Jumper, MD
- Dr. Srinivas Kadiyala, MD
- Dr. Gilbert Berdine, MD
- Dr. Wael Tello, MD
- Dr. Gary Smith, MD
Mailing Address
2215 Nashville Ave
Lubbock, TX 794101105
Phone: 8067255844